earticle

영어

The zoonotic diseases, virus and bacteria-borne, are major concern to the global security. African swine fever (ASF) is high contagious and high mortality haemorrhagic viral disease in domestic and wild boar (Sus scrofa). Bacteria-borne zoonotic diseases such as Salmonella and Shiga toxin-producing Escherichia coli were detected in wild boar (S. scrofa) in Korea. However, ASF is found in almost all countries around the world, particularly in sub-Saharan Africa. The outbreaks have spread through China, Mongolia and Vietnam, South Korea, North Korea, India as well as northeast region Myanmar, Bhutan, and Bangladesh during the last two years. But on 17 September 2019, the first outbreak of African swine fever in a pig farm was confirmed in South Korea. Based on genetic sequence with the phylogenetic analysis ASFV isolates were in South Korea belong to genotype II and serogroup 8. However, genomic characterization whole genomic sequence of ASFV isolates are required for typing, control measures, management, and development of vaccine against ASFV. Till date, there is no effective approved vaccine or antiviral drugs in the market against ASF infection. Therefore, control/prevention and management is the best strategy to handle of the ASF infection. ASF is a transboundary animal disease (TAD) that can be spread by live or dead pigs, domestic or wild, and pork products. The prevention strategies of ASF are early detection, design more cost-effective surveillance e.g. modelling for transmission dynamics, find out the risk factors including role of wild boar and soft ticks, and biosafety and biosecurity measures. In our presentation, we discuss about the viral and bacterial zoonotic diseases in future concerns, cost-effective surveillance, and mitigation measures of zoonotic (ASF) diseases.